Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/GMAB.CO

GMAB.CO

Genmab A/S

Healthcare - DK

Genmab A/S is a Danish biotechnology company that creates, develops and commercializes differentiated antibody therapeutics focused on oncology and other serious diseases; its core offerings include proprietary technologies such as DuoBody,…

HQ: Copenhagen, CD, Denmarkwww.genmab.com

DKK2,083.00-2.39%vs prev. close

Market snapshot

Price

DKK2,083.00

Daily move

-2.39%

P/E

25.8

EPS TTM

81.24

Dividend yield

—

Beta

0.70

Market cap

20.0B

Price history

GMAB.CO price

DKK

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Genmab	GMAB.CO	Biotechnology	20.0	25.8	—	-5.2%	+4.5%	+28.9%	+19.7%	+17.8%	+2.8%

Subscribe to Equity Analytics to compare GMAB.CO with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.